News

Most Recent Press Releases

7/29/2015
Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients

5/7/2015
Plexxikon and Merck to Collaborate on Combination Study Evaluating Investigational Immuno-oncology Regimen

12/11/2014
Plexxikon and QuantumLeap Healthcare Collaborative Announce Selection of PLX3397 for I-SPY 2 TRIAL in Breast Cancer

5/14/2014
Plexxikon Announces Promising Preliminary PLX3397 Phase 1 Extension Data in Patients with Pigmented Villonodular Synovitis (PVNS)

5/14/2014
Plexxikon Announces PLX3397 Data Presentations at ASCO 2014 Annual Meeting

Additional Press Releases

PR Contacts

Susan Kinkead
Kinkead Communications
415.509.3610
susan@kinkeadcomm.com

Jennifer Cook Williams
Cook Williams Communications
360.668.3701
jennifer@cwcomm.org